- Home
- GNLX vs NYMTL Comparison
GNLX vs NYMTL Comparison
Compare GNLX & NYMTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- NYMTL
- Stock Information
- Founded
- GNLX 2001
- NYMTL N/A
- Country
- GNLX United States
- NYMTL United States
- Employees
- GNLX N/A
- NYMTL 79
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- NYMTL Real Estate Investment Trusts
- Sector
- GNLX Health Care
- NYMTL Real Estate
- Exchange
- GNLX Nasdaq
- NYMTL Nasdaq
- Market Cap
- GNLX 103.6M
- NYMTL N/A
- IPO Year
- GNLX 2023
- NYMTL N/A
- Fundamental
- Price
- GNLX $2.27
- NYMTL $22.70
- Analyst Decision
- GNLX Strong Buy
- NYMTL
- Analyst Count
- GNLX 4
- NYMTL 0
- Target Price
- GNLX $18.25
- NYMTL N/A
- AVG Volume (30 Days)
- GNLX 141.5K
- NYMTL N/A
- Earning Date
- GNLX 11-14-2024
- NYMTL N/A
- Dividend Yield
- GNLX N/A
- NYMTL N/A
- EPS Growth
- GNLX N/A
- NYMTL N/A
- EPS
- GNLX N/A
- NYMTL N/A
- Revenue
- GNLX $8,000.00
- NYMTL N/A
- Revenue This Year
- GNLX N/A
- NYMTL N/A
- Revenue Next Year
- GNLX N/A
- NYMTL N/A
- P/E Ratio
- GNLX N/A
- NYMTL N/A
- Revenue Growth
- GNLX N/A
- NYMTL N/A
- 52 Week Low
- GNLX $1.60
- NYMTL N/A
- 52 Week High
- GNLX $16.60
- NYMTL N/A
- Technical
- Relative Strength Index (RSI)
- GNLX 38.68
- NYMTL 52.46
- Support Level
- GNLX $2.13
- NYMTL $22.54
- Resistance Level
- GNLX $2.80
- NYMTL $23.03
- Average True Range (ATR)
- GNLX 0.20
- NYMTL 0.19
- MACD
- GNLX -0.04
- NYMTL -0.05
- Stochastic Oscillator
- GNLX 14.21
- NYMTL 45.00
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.
About NYMTL New York Mortgage Trust Inc. 6.875% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock $0.01 par value per share
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets.